Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients
Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery
Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement
|5||Not yet recruiting||
Lp(a) and Aortic Valve Calcification
† Study has passed its completion date and status has not been verified in more than two years.